Status:
WITHDRAWN
Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Ministry of Health, Israel
Conditions:
HIV Infection
AIDS
Eligibility:
All Genders
18-60 years
Brief Summary
The objective of this proposal is based on the assumption that the HIV infected Ethiopian population responded in a different way in comparison to the Caucasian subjects to Lopinavir therapy. Our prel...
Detailed Description
The objective of this proposal is based on the assumption that the HIV infected Ethiopian population responded in a different way in comparison to the Caucasian subjects to Lopinavir therapy. Our prel...
Eligibility Criteria
Inclusion
- All HIV infected Ethiopian and Non-Ethiopian subjects
- AIDS diseased Ethiopian and Non-Ethiopian individuals
Exclusion
- Individuals who are unable to sign the informed concent
- Individuals unable to take oral medications
- Individuals who described Lopinavir allergy
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00347750
Start Date
September 1 2006
End Date
September 1 2007
Last Update
November 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel, 31096